HIGHLIGHTS
- who: Adetola A. Kassim and Alexis Leonard from the Department of Medicine, Division of Hematology/Oncology, Vanderbilt Meharry Sickle Cell Center of Excellence, Vanderbilt University School of Medicine, Nashville, TN, USA have published the Article: Debating the Future of Sickle Cell Disease Curative Therapy: Haploidentical Hematopoietic Stem Cell Transplantation vs. Gene Therapy, in the Journal: (JOURNAL)
- what: This approach for NMA haplo-BMT was developed to increase donor availability, minimize GvHD, and reduce toxicity.
- future: This has allowed for the extension of this curative approach to individuals with severe SCD (pediatric and adults . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.